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Introduction: The placenta controls nutrient transfer between mother and fetus via membrane transporters.
Appropriate transplacental passage of nutrients is essential for fetal growth and development. We investigated
whether transporter transcript levels in human placenta-liver pairs from ﬁrst and early second trimester preg-
nancies exhibit gestational age- or fetal sex-speciﬁc proﬁles and whether these are dysregulated by maternal
smoking.
Methods: In a step-change for the ﬁeld, paired placenta and fetal livers from 54 electively terminated, normally-
progressing pregnancies (7–20 weeks of gestation, Scottish Advanced Fetal Research Study, REC 15/NS/0123)
were sexed and cigarette smoking-exposure conﬁrmed. Thirty-six nutrient transporter transcripts were quanti-
ﬁed using RT-qPCR.
Results: While fetal, liver and placenta weights were not altered by maternal smoking, levels of transporter
transcripts changed with fetal age and sex in the placenta and fetal liver and their trajectories were altered if the
mother smoked. Placental levels of glucose uptake transporters SLC2A1 and SLC2A3 increased in smoking-
exposed fetuses while smoking was associated with altered levels of amino acid and fatty acid transporter genes
in both tissues. SLC7A8, which exchanges non-essential amino acids in the fetus for essential amino acids from
the placenta, was reduced in smoking-exposed placentas while transcript levels of four hepatic fatty acid uptake
transporters were also reduced by smoking.
Discussion: This data shows that fetal sex and age and maternal smoking are associated with altered transporter
transcript levels. This could inﬂuence nutrient transport across the placenta and subsequent uptake by the fetal
liver, altering trophic delivery to the growing fetus.
1. Introduction
The placenta ensures appropriate passage of nutrients from the
maternal circulation to the fetal circulation. Control of nutrient avail-
ability to the fetus is vital and abnormal birthweight is linked to disease
incidence later in life [1]. Since fetal nutrient demand is not met by
diﬀusion alone, nutrient availability in the fetal compartment is de-
pendent on appropriate expression proﬁles of placental membrane
transporters in the syncytiotrophoblast and fetal capillaries. Transpla-
cental transfer of amino acids, fatty acids, glucose and cholesterol, es-
sential nutrients for fetal development, is mediated by well-char-
acterised syncytial membrane transporters in the human placenta
(Fig. 1). However, information on other placental transporters is sparse
and conﬂicting [2]. Unfortunately, most data available are from term
placentas and expression patterns across gestation, particularly in the
early second trimester, are inadequately understood. Uptake of nu-
trients into the fetal liver depends, similarly, on these uptake trans-
porters, although their expression in the fetal liver is also poorly
characterised. Characterising these patterns of expression and how they
can be changed by maternal factors is important to better understand
how modiﬁable maternal lifestyle can inﬂuence placental function and
fetal development.
Of the blood supply received by the fetal liver, 70% is directly from
the umbilical vein [3] making the liver a checkpoint for distribution of
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maternally derived nutrients, after the placenta. Our understanding of
the functional partnership between the fetal liver and placenta remains
to be fully realized, but the concept that it is an interactive relationship
is well established [4]. Additionally, the organization of the syncytio-
trophoblast is unique to humans, so understanding placental transport
and placenta/liver interactions cannot rely only on animal studies.
Maternal lifestyle factors such as smoking [5–7], diet [8] and al-
cohol consumption [9] during pregnancy are known to inﬂuence pla-
cental function. Maternal smoking remains the largest avoidable factor
for poor pregnancy outcome. Indeed, expression of amino acid trans-
porter genes (SLC7A5/6) are known to be altered by pre-pregnancy
smoking in term placentas [10]. The impacts of maternal smoking on
metabolic enzyme [11] and protein [12] expression in the human fetal
liver have been reported, and direct eﬀects of cigarette smoke compo-
nents demonstrated in cultured hepatoblasts [13]. Data on expression
of fetal hepatic nutrient transporters, and the inﬂuence of smoking,
remains sparse, however. Outlining the relationship between maternal
factors, alterations in gene expression and the fetal growth trajectory
would be essential information to allow potential windows for inter-
vention to be identiﬁed and to allow development of biomarkers for
altered fetal growth. Understanding how modiﬁable maternal factors
perturb normal placental function would also give clear guidelines to
mothers, which would help to ensure the best chance of a healthy post-
natal life for the fetus.
Taking these considerations together, we have, for the ﬁrst time,
examined transporter transcript levels of four major nutrient trans-
porter groups in ﬁrst and second trimester human placentas and
matching fetal livers from the same pregnancies. It is well accepted that
maternal smoking harms the fetus but the mechanisms underlying the
eﬀect are less well known. The fetal liver plays a central role in fetal
physiology as well as being a substantial endocrine organ and it cannot
be ignored when investigating the in utero impact of smoking exposure
on the human fetus. We hypothesize that nutrient transporter tran-
scripts in the placenta and fetal liver will be altered by maternal
smoking and this exposure may not aﬀect both organs in the same way.
2. Materials & methods
2.1. Tissue acquisition
The collection of human fetal material was approved by the
National Health Service (NHS) Grampian Research Ethics Committees
(REC 15/NS/0123). Women over the age of 16 and with a good un-
derstanding of English could consent to take part in the Scottish
Advanced Fetal Research (SAFeR) study without any change in treat-
ment. The products of conception (fetus and placenta) from electively
terminated, normally-progressing pregnancies (7–20 weeks gestation)
were collected within 3 hours of delivery. Fetal measurements were
taken e.g. body weight, crown-rump length (CRL), and anogenital dis-
tance. Umbilical cords, fetal membranes, maternal decidua and any
blood clots were removed from placentas prior to weighing. Each pla-
cental sample consisted of 6 full-thickness biopsies which were com-
bined then snap-frozen and pulverized in liquid nitrogen to form a re-
presentative powder. Fetal livers were removed whole and weighed
after the gall bladder was removed (where possible). A 30mg sample
was taken from the main/right lobe of the liver and snap-frozen. All
tissues were stored at −80 °C.
2.2. Maternal and fetal data
In order to preserve maternal anonymity, maternal health in-
formation (BMI, medication etc) routinely collected by independent
pregnancy nurse specialists was entered onto study-speciﬁc anonymised
forms. The nurses sent maternal data to NHS Grampian Data Safe Haven
(DaSH) and anonymous Scottish Index of Multiple Deprivation (SIMD)
scores (as vigintiles) were returned to the research team. SIMD uses 7
criteria: income (28%), employment (28%), health (14%), education,
skills and training (14%), housing (2%), access to services (9%) and
crime (5%) to estimate level of deprivation on a scale of 0–20 [14]. The
cohort described here are equally spread across this scale. Patients were
asked to complete the Fast Alcohol Screening Test (FAST) [15]. This is a
validated questionnaire which assesses amount and frequency of al-
cohol intake. Fetal gestation was calculated from measurements of fetal
Fig. 1. Schematic summary of transplacental nutrient transport via membrane transport proteins. Placental nutrient transporters (gene name in italics) with
conﬁrmed syncytiotrophoblast location. Uptake of nutrients from maternal circulation occurs on the apical membrane where villous trees are in contact with
maternal blood. Transport direction of the main nutrient groups also shown. Non-essential amino acids are taken up by sodium dependent transporters (System A).
These non-essential amino acids can be exchanged for essential amino acids by a sodium independent exchanger (System L). Glucose is transported via GLUT1 and
GLUT3 and an asymmetrical expression pattern maintains glucose gradient favourable of transport towards fetal capillaries. GLUT4 is stored in syncytial cytoplasm
and responsible for increased glucose transport under insulin stimulation in early stages of pregnancy. Maternal TG are converted to FFA by cytoplasm-associated
lipases (endothelial and lipophilic) where they are taken up by FATP or FAT then bound to FABP for traﬃcking towards fetus. FABPpm has high aﬃnity for LCPUFA.
FFA can diﬀuse across syncytiotrophoblast (broken line) but not at an adequate rate to meet fetal requirement. Maternal cholesterol is taken up by SR-1B, SR-A, LDL
receptor or VLDL receptor and is believed to exit the syncytiotrophoblast by ABCA1 and ABCG1 (note ABCA1 is also expressed apically). ABC ATP-binding cassette;
CERP cholesterol eﬄux regulatory protein; EL endothelial lipase; FABP fatty acid binding protein; FABPpm plasma membrane fatty acid binding protein; FAT fatty
acid translocase; FATP fatty acid transporter protein; FFA free fatty acids; HDL high-density lipoprotein; LDL low-density lipoprotein; LPL lipoprotein lipase; SR
scavenger receptor; TG triglycerides; VLDL very low-density lipoprotein.
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foot-length taken by ultrasound scan prior to termination of pregnancy.
Maternal and fetal information is summarised in Table 1.
2.3. Transcript and cotinine analysis
54 paired placenta and liver samples from the same fetus were sexed
(by presence/absence of Y-speciﬁc gene, SRY) and smoke exposure
validated by measurement of placental cotinine, an active metabolite of
nicotine, using LC-MS/MS (Supplementary Method 1). The cotinine
range for non-smokers was<5 ng/g wet tissue weight and for smokers
it was≥10 ng/g. DNA, RNA and protein were extracted simultaneously
from tissues (∼30mg) using Qiagen Mini-prep kits (Qiagen Ltd), in-
cluding a DNAse step (Qiagen RNase-Free DNase Set) according to
manufacturer's guidelines. RNA was reverse transcribed using a
GoScript Reverse Transcriptase kit (Promega). For quantitative real-
time PCR (RT-qPCR), primers were designed to amplify nutrient
transporter transcripts using Primer-BLAST (https://www.ncbi.nlm.nih.
gov/tools/primer-blast/) (Table S1), with criteria set as previously
described [16]. Transcript expression was quantiﬁed by RT-qPCR
(LightCycler 480 SYBR Green I Master, Roche) (Roche LightCycler
480). Samples were run in duplicate against a 6 point standard curve for
each transcript (Absolute Quantiﬁcation analysis) using parameters;
95 °C for 5min, 45 cycles of 95 °C for 15 s, 63 °C for 15 s and 72 °C for
15 s followed by a melting curve. A selection of samples were repeated
across plates to test for inter-plate variation. To identify appropriate
house-keeping genes (HKG) for these studies; data from 7 (placenta)
and 4 (liver) candidate HKG were compared using NormFinder.xla
Excel add-in (Table S2) to check stability across gestational age, fetal
sex and smoking-exposure. Succinate dehydrogenase A (SDHA) was the
most stable in both placenta and fetal liver (both M=0.004). Nor-
malised cycle threshold values for each gene (mean ± SEM) can be
found in Supplementary Table S3.
2.4. Statistical analysis
Statistical analyses were performed in R statistical software version
3.5.1 using our established linear modelling approach [17] with fetal
age (continuous), fetal sex (categorical) and smoking-exposure (cate-
gorical, conﬁrmed by cotinine), as covariates both singly and in com-
bination. To ensure that maternal alcohol use did not interact with
maternal smoking, we included FAST score in our linear model (FAST
score + age*sex*smoking-exposure). Signiﬁcance was accepted at
P < 0.05.
3. Results
Cotinine concentrations correlated closely between the fetus (re-
presented by a fetal liver sample) and placenta (R-squared=0.82,
P < 0.001, Supplementary Fig. S1). There were no diﬀerences in fetal,
placental and liver weights; crown-rump length (CRL); or ponderal
index (fetal weight/CRL3) between smoking-exposed and control fe-
tuses in the SAFeR cohort (Table 1). Maternal factors, such as alcohol
use, were not signiﬁcantly diﬀerent between smokers and non-smokers
(Supplementary Fig. S2). Time elapsed between delivery to processing
of tissue did not aﬀect results (Supplementary Fig. S3).
3.1. Developmental ontogeny of nutrient transporter transcripts
Levels of transcripts encoding twenty-two transporters changed
across gestational age in the placenta, with the majority (16/22) in-
creasing with advancing gestation. Conversely, levels of 18/36 tran-
scripts were altered by fetal age in the fetal livers, with the majority
decreasing (10/18) with advancing gestation. There was consensus in
the changing transcript levels between the placenta and liver for
SLC3A2, SLC27A6 and GOT2 (all ↓) and for SLC2A4, SLC38A2 and
CD36 (all ↑) (Table 2).
3.2. Eﬀects of maternal smoking on nutrient transporter levels in the
placenta
Transporter transcript levels were aﬀected by smoking-exposure in
the placenta (Fig. 2). SLC27A4 was decreased compared with controls
when the mother smoked (Fig. 2A, P=0.02) and was associated with a
greater rate of increase in SLC7A6 (P=0.003), and SLC16A10
(P=0.002) levels during gestation (Fig. 2B). A further four amino acid
transporter transcripts were signiﬁcantly inﬂuenced by smoking with
SLC7A7 increasing (P=0.03) and SLC38A2 (P=0.05), SLC1A2
(P=0.01) and SLC7A8 (P=0.01) decreasing. SLC7A8 encodes one
subunit of a heterodimer, and its ratio with the second subunit, SLC3A2,
showed the same association with smoking (P=0.02). Transcripts
encoding two major placental glucose uptake transporters (SLC2A1 and
SLC2A3) were upregulated in smoking-exposed placentas (Fig. 2C, both
P=0.01). Results from studies examining the eﬀects of smoking and
gestational age have been compared to relevant literature from 1st, 2nd
and term placenta in Table 3.
Table 1
Placentas and fetuses collected between 7 and 20 weeks of gestation.
SAFeR cohort Placenta-liver pair qPCR cohort
Control (n= 113) Smoking-exposed (n=64) P-value Control (n= 33) Smoking-exposed (n= 21) P-value
Maternal age 27.3 ± 0.7 25.9 ± 0.8 0.23 25.8 ± 1.3 25.1 ± 0.9 0.69
Maternal BMI 26.7 ± 0.6 26.2 ± 0.6 0.56 27.8 ± 1.4 24.6 ± 1 0.10
FAST score 1.5 ± 0.1 1.6 ± 0.2 0.59 1.8 ± 0.3 1.1 ± 0.2 0.08
SIMD score 12.6 ± 0.5 11.5 ± 0.6 0.17 11.1 ± 0.9 11.6 ± 1 0.76
Placenta weight (g) 33.2 ± 3.2 29.1 ± 3.2 0.40 44.3 ± 7.5 29.3 ± 4.2 0.12
Cotinine (ng/g) 0.02 ± 0.01 110.5 ± 15.5 < 0.001*** 0.1 ± 0.1 113.4 ± 16.7 < 0.001***
Fetal age 10.9 ± 0.3 10.9 ± 0.4 0.78 12 ± 0.6 11.2 ± 0.6 0.37
Fetal sex F= 50M=55 F=29M=34 n/a F= 16M=15 F=13M=10 n/a
Fetal weight (g) 30.9 ± 5.6 21.5 ± 4.8 0.24 45.4 ± 12 24.8 ± 9.2 0.21
Liver weight (g) 1.5 ± 0.3 1.2 ± 0.3 0.44 2 ± 0.5 1.1 ± 0.4 0.19
CRL (mm) 62.6 ± 4.5 61 ± 5.4 0.82 71.6 ± 8.9 56.8 ± 8.1 0.25
Ponderal index (mg/mm3) 0.1 ± 0.003 0.1 ± 0.003 0.31 0.1 ± 0.01 0.1 ± 0.004 0.35
No signiﬁcant diﬀerences were seen in maternal and fetal characteristics between smoking-exposed and control groups in both SAFeR (to date) and placenta-liver
pair (current study) cohorts except cotinine level, shown in bold. P-values derived from t-tests. FAST total score indicates frequency and severity of alcohol intake.
SIMD low numbers indicate more deprived areas. BMI: body mass index (kg/m2); CRL: crown-rump length; F: female; FAST: fast alcohol screening test; M: male;
SIMD: Scottish Index of Multiple Deprivation. Ponderal index is an index of fetal leanness. Values shown as mean ± SEM.
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3.3. Eﬀect of maternal smoking on nutrient transporter transcript levels in
the fetal liver
All placental nutrient transporters quantiﬁed were also expressed in
the fetal liver. Smoking-exposure was associated with changes to
transcripts involved in fatty acid, amino acid and glucose traﬃcking
(Fig. 3). Hepatic levels of two fatty acid transporters (SLC27A1 and
SLC27A4, Fig. 3A), three amino acid transporters (SLC6A6, SLC7A6 and
SLC16A10, Fig. 3B), and a glucose transporter (SLC2A4, Fig. 3C) were
all decreased (P < 0.05) in smoking-exposed fetuses. Smoking-ex-
posure was associated with decreased SLC27A2 transcript levels while
controls remained stable with fetal age. Levels of SLC27A3 and SLC3A2
decreased with age in control fetuses and the rate of this decline was
accelerated by maternal smoking (both P=0.01). SLC3A2 encodes a
chaperone protein required for function of LAT1 and LAT2 (encoded by
SLC7A5, SLC7A8 respectively) but these transcripts were unaﬀected by
smoking-exposure in the fetal liver.
3.4. Eﬀect of fetal sex on nutrient transporter transcript expression
Some transporters exhibited sex-speciﬁc patterns of transcript levels
across the fetal age range analysed (Supplementary Fig. S4). In the fetal
liver, levels of SLC7A8 and SLC1A7 were decreased in males compared
to females (P=0.04, P=0.05 respectively) while, in the placenta,
Table 2
Gestational expression patterns of nutrient transporter transcripts.
Gene Substrate Placenta Liver Gene Substrate Placenta Liver
SLC7A5 neutral AA, thyroid hormone ↓
*
↑* SLC2A1 glucose uptake - -
SLC7A8 neutral AA, thyroid hormone - ↑*** SLC2A3 glucose uptake/export - -
SLC43A1 branched chain AA, phenylalanine ↑*** - SLC2A4 glucose uptake early pregnancy (insulin sensitive) ↑*** ↑***
SLC42A2 neutral AA - ↓*** SLC2A9 glucose uptake - ↑*
SLC1A4 alanine, serine, cysteine, threonine ↑*** ↓* SLC27A1 Long chain fatty acids ↑* -
SLC1A5 neutral and zwitterionic AA ↑
**
- SLC27A2 Long chain fatty acids/FA metabolism - -
SLC7A7 neutral and zwitterionic AA ↑
***
↓
***
SLC27A3 Long chain fatty acids - ↓**
SLC7A6 arginine, leucine and glutamine - ↓*** SLC27A4 Long chain fatty acids - ↓**
SLC3A2 chaperone ↓** ↓*** SLC27A6 Long chain fatty acids ↓*** ↓**
SLC1A3 L-glutamate, L/D-aspartate ↑*** ↓** GOT2 Long chain fatty acids ↓* ↓**
SLC1A2 L-glutamate, L/D-aspartate ↓*** ↑*** CD36 Long chain fatty acids ↑*** ↑*
SLC1A1 L-glutamate, L/D-aspartate, L-cysteine ↑*** - MSR1 Low-density lipoproteins ↑*** -
SLC1A6 L-glutamate, L/D-aspartate ↑* - SCARB1 High-density lipoproteins ↑* -
SLC1A7 L-glutamate - - LDLR Low and very low-density lipoproteins - ↑**
SLC38A1 Glutamine, sodium ions ↓
*
- VLDR Very low-density lipoproteins - -
SLC38A2 neutral AA, sodium ions ↑*** ↑*** ABCA1 Cholesterol and phospholipids ↑* -
SLC38A4 neutral AA, preference for alanine - - ABCG1 Cholesterol and phospholipids ↑*** -
SLC16A10 aromatic acids ↑*** -
SLC6A6 taurine, beta-alanine - -
Ontogeny of transcript expression in human placenta and fetal liver pairs normalised against SDHA. Substrate of corresponding membrane transporter given
(source:UniProt). AA amino acids; ¶ transcripts encode subunits of a heterodimeric transporter; ↑ increases with gestational age; ↓ decreases with gestational age; -
stable across gestation. *P < 0.05 **P < 0.01 ***P < 0.001.
Fig. 2. Maternal smoking is associated with changes in expression levels and gestational expression patterns of placental nutrient transporter transcripts.
Maternal smoking altered levels (shown as histograms) and gestational age patterns (shown as age plots) of transcripts coding for membrane transporters involved in
transport of; fatty acids (A), amino acids (B), and glucose (C) in the human placenta. Transporter transcripts that were not changed by fetal sex and transcripts
showing no smoking eﬀects are not shown. All data was normalised to SDHA. Histograms show mean ± SEM and age plots multi-variate regression using the linear
model (transcript ∼ age*smoking-exposure). n = 54 placentas, per group: n = 33 controls and n = 21 smoking-exposed. ¶ Transcript encodes subunit of a
heterodimeric transporter protein.
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Table 3
Comparison of SAFeR placental results to relevant literature.
gene covariate SAFeR (n=54) other studies trimester sample size references Comments
AMINO ACID TRANSPORTER TRANSCRIPTS
SLC7A5 age ↓ ↑ Early 2nd vs term 6 [38] protein
↑ Early 2nd vs term 23 [39]
smoking - - term 102 [10]
SLC7A8 age - - All 23 (2nd & term)
8 (1st & term
[39]
smoking ↓ ↑ term 102 [10] pre-pregnancy smoking
SLC43A1 age ↑ ↑ term 102 [40] ↑ with fetal growth indices, not fetal age
- All 23 (2nd & term)
8 (1st & term
[39]
smoking - - term 102 [10]
SLC42A2 age - No relevant study found
smoking - - term 102 [10]
SLC1A4 age ↑ ↓ Early 2nd vs term 23 [39]
smoking - - term 102 [10]
SLC1A5 age ↑ - Pre-term (34.8) vs term 20 [41] Protein, small age range
- All 23 (2nd & term)
8 (1st & term
[39]
smoking - - term 102 [10]
SLC7A7 age ↑ - Pre-term (33.8) vs term (38.8) 9 [42] Protein, small age range
↓ Early 2nd & term 23 [39]
smoking ↑ - term 102 [10] pre-pregnancy smoking
SLC7A6 age - - All 3 23 (2nd & term)
8 (1st & term
[39]
smoking ↑age ↑ term 102 [10] pregnancy smoking
SLC3A2 age ↓ - Pre-term (34.8 wks) vs term 20 [41] Protein, small age range
- All 3 23 (2nd & term)
8 (1st & term
[39]
smoking - - term 102 [10]
SLC1A3 age ↑ ↓ Early 2nd vs term 23 [39]
smoking - - term 102 [10]
SLC1A2 age ↓ ↓ 1st vs term 8 [39]
smoking ↓ - term 102 [10]
SLC1A1 age ↑ - All 23 (2nd & term)
8 (1st & term)
[39]
smoking - - term 102 [10]
SLC1A6 age ↑ - All 23 (2nd & term)
8 (1st & term)
[39]
smoking - - term 102 [10]
SLC1A7 age - - All 23 (2nd & term)
8 (1st & term)
[39]
smoking - - term 102 [10]
SLC38A1 age ↓ - 1st vs term 56 [43]
- All 23 (2nd & term)
8 (1st & term)
[39]
smoking - - term 102 [10]
SLC38A2 age ↑ ↑ All 23 (2nd & term)
8 (1st & term)
[39]
- 1st vs term 56 [43]
smoking ↓ - term 102 [10]
SLC38A4 age - - All 23 (2nd & term)
8 (1st & term)
[39]
↓ 1st vs term 56 [43]
smoking - - term 102 [10]
SLC16A10 age ↑ - All 23 (2nd & term)
8 (1st & term)
[39]
smoking ↑age - term 102 [10] pre-pregnancy smoking
SLC6A6 age - - 1st vs term 56 [44] Transcript and protein agreed
smoking - - term 61 [28] TauT activity, not expression, few smokers
(n= 5)
GLUCOSE TRANSPORTER TRANSCRIPTS
SLC2A1 age - ↑ 1st vs term 45 [32] protein
smoking ↑ No relevant study found
SLC2A3 age - ↓ All 22 [33] protein
smoking ↑ No relevant study found
SLC2A4 age ↑ ↓ 1st vs term 45 [32] Transcript & protein
smoking - No relevant study found
SLC2A9 age - No relevant study found
smoking - No relevant study found
FATTY ACID TRANSPORTER TRANSCRIPTS
SLC27A1 age ↑ No relevant study found
smoking - No relevant study found
SLC27A2 age - No relevant study found
smoking - No relevant study found
(continued on next page)
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SLC27A6 was increased in males compared to females (P=0.04).
4. Discussion
In this study we have characterised transcript proﬁles of a large
panel of key nutrient transporters in normal human ﬁrst and second
trimester placentas and paired fetal livers from the same pregnancies.
The placenta is the route of delivery of nutrients to the fetus while the
fetal liver is one of the initial fetal organs at which these nutrients can
be distributed to the rest of the fetus. Studying both organs simulta-
neously from the same fetus in the ﬁrst and second trimester of human
pregnancy represents a ﬁrst in the ﬁeld. Our results show that maternal
smoking is associated with signiﬁcant changes in transcript levels for
some of the key nutrient transporters studied. This may, therefore, be a
fundamental way in which maternal smoking could aﬀect eventual
transporter activity with knock-on eﬀects on fetal growth and devel-
opment and longer-term eﬀects postnatally.
The current study is limited to investigation of mRNA levels and
takes no account of translational or post-translational modiﬁcations.
The results need to be treated with suitable caution, therefore, and
more work is needed to fully understand the eﬀects of maternal lifestyle
on transporter activity and consequent nutrient allocation to the fetus.
Table 3 (continued)
gene covariate SAFeR (n=54) other studies trimester sample size references Comments
SLC27A3 age - No relevant study found
smoking - No relevant study found
SLC27A4 age - No relevant study found
smoking ↓ No relevant study found
SLC27A6 age ↓ No relevant study found
smoking - No relevant study found
GOT2 age ↓ No relevant study found
smoking - ↑ term 102 [10] Pre-pregnancy smoking
CD36 age ↑ No relevant study found
smoking - No relevant study found
CHOLESTEROL/LIPID TRANSPORTER TRANSCRIPTS
MSR1 age ↑ No relevant study found
smoking - No relevant study found
SCARB1 age ↑ ↓ 1st vs term Cell culture [45] mRNA and protein agreed
smoking - No relevant study found
LDLR age - ↓ All 26 [46]
smoking - ↓ term Cell culture [36]
[37]
Cadmium only, in vitro
VLDLR age - ↑ 1st vs term 11 [47] Small n, term placentas were laboured
smoking - No relevant study found
ABCA1 age ↑ ↓ Pre-term (32.8 wks) vs term
(39.1 wks)
29 [48]
- 1st vs term 48 [49] Transcript and protein
↑ 1st vs term 20 [50] 1st trimester only 7–9wks
smoking - No relevant study found
ABCG1 age ↑ - Pre-term (32.8 wks) vs term
(39.1 wks)
26 [48] Transcript and protein
smoking - No relevant study found
Fig. 3. Maternal smoking is associated with changes in expression levels and gestational expression patterns of nutrient transporter transcripts in the fetal liver.
Maternal smoking altered levels (shown as histograms) and gestational age patterns (shown as age plots) of transcripts coding for membrane transporters involved in
transport of; fatty acids (A), amino acids (B) and glucose (C) in the human fetal liver. Transporter transcripts that were not changed by fetal sex and transcripts
showing no smoking eﬀects are not shown. All data was normalised to SDHA. Histograms show mean ± SEM and age plots multi-variate regression using the linear
model (transcript ∼ age*smoking-exposure). n = 54 placentas, per group: n = 33 controls and n = 21 smoking-exposed. ¶ Transcript encodes for subunit of a
heterodimeric transporter protein.
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Nevertheless, alterations in transcript expression are a recognised way
in which changes in cellular activity can occur and this represents a ﬁrst
step towards understanding how maternal smoking aﬀects nutrient
transport in the ﬁrst and second trimesters. In addition, diﬀerential
methylation of genes occurs in the placentas of smokers compared to
non-smokers [18,19] which oﬀers a potential mechanism for how
smoking can cause changes in gene expression. There is evidence gene
expression can diﬀer between the lobes of the liver in fetal baboons
[20]. However, we believe there was no accounting for False Discovery
Rates and a signiﬁcant proportion of these gene diﬀerences could be
due to higher levels of white blood cells and lower levels of hepato-
cytes. The liver samples in the current study were taken from the right
lobe as it is the larger lobe and 30mg tissue can be taken at all gesta-
tional ages to ensure consistent downstream analysis. Whether there are
signiﬁcant gene expression pattern diﬀerences between hepatic lobes in
the human fetal liver is subject to studies beyond the scope of the
current manuscript.
It is well documented that women who smoke during pregnancy are
more likely to have a neonate which is small for gestational age [21].
Given that ultrasound in the ﬁrst and second trimester fails to predict
growth restriction [22] and smoking eﬀects on fetal size are mainly
seen in the third trimester [23], it was unsurprising that we did not see
any gross morphological diﬀerences in smoking-exposed fetuses. The
placenta undergoes structural changes throughout pregnancy and ma-
ternal smoking has been shown to aﬀect villous structure [24]. Thus, it
is possible that changes in cellular composition in response to maternal
smoking could contribute to the observed changes in transcript levels in
the current study.
Those transporter transcripts which increase towards the end of the
second trimester in liver and placenta are likely to reﬂect the rise in
fetal demand for those nutrients. Similarly, those transporters that de-
crease over the same period may reﬂect either less of a need for the
substrate, or less of a need to source the substrate maternally. For nine
genes, the developmental trajectories matched what is seen at term
(Table 3). Where both placental and liver transcript patterns change,
more than half were in the same direction as fetal age which suggests a
hepatic response to changing nutrient eﬄux from the placenta.
Previous studies have tried to characterise amino acid transporter
expression across gestation. These trajectories are often contradictory,
as demonstrated by the comparisons between this study and others
(Table 3). Nevertheless, seven amino acid transporter transcripts dis-
played age patterns which agree with other studies and often match
what is seen at term (i.e. SLC1A2). When examining expression of in-
dividual transporters, our ﬁndings generally agreed with Day and col-
leagues [10]. SLC7A6 was increased by smoking in both studies and
where we did not see an association with maternal smoking, neither did
they. Conversely, some ﬁndings diﬀered (SLC7A7, SLC7A8 and
SLC16A10) but were only signiﬁcantly associated with pre-pregnancy
smoking rather than smoking exposure in utero. Maternal smoking has
been reported to depress amino acid transport activity in the placenta
[25] but the number of placentas studied was not large (a quarter of our
cohort) and some were laboured which could alter transport activity
and smoking-exposure was based on maternal admission only, missing
any second-hand exposure.
SLC7A8, along with SLC3A2, encode a heterodimeric exchanger
which localises to both sides of the plasma membrane and trades non-
essential amino acids for essential amino acids from the syncytial cy-
toplasm [26], directing them towards the fetus. Decreased levels may
reﬂect disruption of this process in smoking-exposed placentas. Due to
the broad substrate proﬁle of SLC7A8, transfer of several amino acids
may be aﬀected. TauT/SLC6A6 transports taurine which is thought to
be essential for development since it is the most abundant amino acid in
the placenta and also has cytoprotective functions [27]. Levels of
SLC6A6 were not associated with maternal smoking in our 1st and early
2nd trimester placentas and Ditchﬁeld et al. [28] demonstrate that TauT
activity is not inﬂuenced by maternal smoking at term. Nevertheless, a
smoking-associated decrease of SLC6A6 was seen in fetal livers in the
current study which may aﬀect hepatic uptake of taurine.
It is thought that the main source of fetal glucose is maternally
derived [29,30]. SLC2A1 and SLC2A3 encode well characterised glu-
cose-uptake transporters in the placenta and, if the smoking eﬀects
found in the current study are translated to functional protein, the
transplacental glucose gradient could be aﬀected as this is dependent
on asymmetrical distribution of transporters on the plasma membrane
(Fig. 1). GLUT4 (encoded by SLC2A4) is believed to take up 50% of the
body's glucose [31] and we show lower SLC2A4 levels in the fetal liver
if the mother smoked. Such alterations to glucose availability could lead
to fetal hyper/hypoglycaemia. Smoking-exposure literature was scarce
for SLC2A/GLUT transporters (Table 3) and gestational trajectories
found in the current study did not agree well with protein studies from
other literature [32,33]. Our results are the ﬁrst to show an association
between maternal smoking and GLUT mRNA expression in the human
fetus and its placenta.
Fatty acids are the highest energy requirement of the fetus [34].
SLC27A4/FATP4 is the most abundant long chain fatty acid uptake
transporter and the smoking-induced change could have implications
for transplacental movement of fatty acids. Four of the seven fatty acid
transporters studied reduced in the liver by smoking and if this mRNA
ﬁnding translates to functional protein; reduced hepatic fatty acid up-
take could be a consequence. Day et al. [10] have reported increased
GOT2 in placentas where the mother was a former smoker but we saw
no association with pregnancy smoking. In an ex vivo perfusion model
of the term placenta, fatty acid transport activity was reported to be
unaﬀected by maternal smoking [35] albeit with a small sample size
(n= 10). There are no other studies of gestational expression or
smoking-exposure eﬀects on fatty acid transporters in the human pla-
centa.
Smoking-exposure did not alter the expression levels of MSR2,
SCARB1, LDLR, VLDLR, ABCA1 or ABCG1 in either the placenta or the
fetal liver in this study. Two previous studies [36,37] have shown that
cadmium, a component of cigarette smoke, is associated with a re-
duction in expression of the LDL receptor in vitro. We did not see an
association with exposure to maternal smoking and LDLR (P=0.69). It
is likely, therefore, that the levels of cadmium reaching the placenta/
fetal liver in vivo do not reach those used in vitro.
In conclusion, our study of paired placenta and livers from the same,
normally progressing human pregnancy has characterised expression
patterns of key nutrient transporters across a wide pregnancy window,
from 7 to 20 weeks gestation. We report that cigarette smoking, a
modiﬁable maternal habit, is associated with changes in transcript level
of nine nutrient transporters in the placenta (eight in the matching li-
vers). These ﬁndings highlight a vulnerability for the fetus, especially in
the placenta as changes in transporter function are likely to alter nu-
trient delivery to the fetal compartment and adversely impact on
overall fetal growth and development.
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